GHD is the market leading homecare provider in Germany, delivering medical products, advice and services to more than 140,000 patients.The company operates in the German healthcare market, which is characterised by positive long-term demand driven by demographic trends.

GHD operates as a truly integrated business including the production of medical supplies and compounded pharmaceuticals, and strong wholesale and logistics activities. Since its inception in 1992, GHD has developed strong relationships with the relevant stakeholders in this field, such as hospitals, doctors, nursing homes and statutory health insurers.

GHD's homecare business provides services in combination with the provision of consumable medical devices that require personal consultation and explanation. GHD does this through an unparalleled network of nurses and trained medical staff across Germany. In addition, GHD is a leading producer of custom-made infusion solutions for cytostatic drugs and parenteral nutrition. The company operates through a network of certified state-of-the-art production facilities across Germany.

Nordic Capital Fund VIII acquired a majority stake in GHD in 2014 with the ambition to support continued accelerated growth, both organically and through acquisitions, within existing homecare and adjacent healthcare segments, as well as by developing new business areas.


Sector Icon


Key Information

Revenues Icon

Revenues 2021*

EUR 585 million

Employees Icon



Ownership Icon


Nordic Capital Fund VIII, controlling shareholding

Head Office Icon

Head office

Ahrensburg, Germany

Investment Icon

Investment date


* Reported